Expression of Perilipin A on the Surface of Lipid Droplets Increases along with the Differentiation of Hamster Sebocytes In Vivo and In Vitro  by Akimoto, Noriko et al.
Expression of Perilipin A on the Surface of Lipid Droplets
Increases along with the Differentiation of Hamster
Sebocytes In Vivo and In Vitro
Noriko Akimoto, Takashi Sato, Chikakazu Iwata, Masayuki Koshizuka, Fusatoshi Shibata,
Ayako Nagai,w Michihiro Sumida,w and Akira Ito
Department of Biochemistry and Molecular Biology, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Hachioji, Tokyo, Japan; wDivision
of Biochemistry and Molecular Genetics, Department of Molecular and Cellular Biology, Ehime University School of Medicine, Onsen-gun, Ehime, Japan
To clarify the involvement of perilipin, a lipid-droplet-surface protein associated with adipocytes and steroidogenic
cells, in the differentiation of sebocytes, we investigated the expression of perilipin in sebaceous glands in vivo and
in vitro. Perilipin was expressed in sebaceous glands of the hamster auricle in vivo and was localized at the surface
of intracellular lipid droplets in differentiated hamster sebocytes in vitro. Western blot analysis showed that
perilipin with a molecular weight of approximately 57 kDa, which was identical to that in differentiated mouse
3T3-L1 adipocytes, was detected in cultured sebocytes, indicating that sebaceous glands expressed perilipin A.
In addition, the production of perilipin A in cultured sebocytes was transcriptionally augmented by sebocytic–
lipogenesis stimulators, insulin, and 5a-dihydrotestosterone, whereas it was decreased by a suppressor of
sebocytic differentiation, epidermal growth factor. Furthermore, hamster sebocytes were found to express per-
oxisome proliferation-activating receptor a and c1, the activation of which by WY14643 and troglitazone, respec-
tively, caused the transcriptional augmentation of perilipin A expression along with an increase in levels of
triacylglycerols in lipid droplets in sebocytes. Therefore, these results provide novel evidence that the expression
of perilipin A increases on the surface of intracellular lipid droplets augmented along with the differentiation of
hamster sebocytes.
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Differentiation of sebaceous gland cells (sebocytes) is de-
fined by accumulating intracellular lipid droplets, and the
holocrine secretion of sebaceous lipids (sebum) plays an
important role in maintaining physiological functions by
forming a biological barrier in the skin (Thody and Shuster,
1989; Zouboulis et al, 1998; Abramovits and Gonzalez-Se-
rva, 2000; Harper and Thiboutot, 2003). Sebocytic differen-
tiation has been controlled by various physiological factors,
such as hormones and growth factors. Androgens, such as
testosterone and 5a-dihydrotestosterone (5a-DHT), and in-
sulin are principal regulators to stimulate lipid-droplet for-
mation in sebaceous glands in vivo and in vitro (Sawaya
et al, 1989; Zouboulis et al, 1994; Rosenfield et al, 1998;
Deplewski and Rosenfield, 1999; Sato et al, 2001). In con-
trast, estrogen, retinoic acid, epidermal growth factor (EGF),
and 1a, 25-dihydroxyvitamin D3 have been reported to
suppress the differentiation of sebocytes in humans and
rodents (Orfanos and Zouboulis, 1998; Sato et al, 2001;
Akimoto et al, 2002).
As in the case of sebocytes, adipocytes differentiate to
accumulate abundant intracellular neutral lipids in the cy-
toplasm (Bjorntorp et al, 1980; Smith et al, 1988). Perilipin,
which is identified as a phosphoprotein that is located on
the periphery of lipid droplets in adipocytes and steroid-
ogenic cells, has been involved in the regulation of lipid
metabolism (Greenberg et al, 1991; Servetnick et al, 1995;
Londos et al, 1999). In addition, four isoforms of perilipin
(perilipin A, B, C, and D) have been identified as alternative
mRNA splicing variants (Lu et al, 2001), and their expression
has been regulated by tumor necrosis factor-a and insulin at
transcriptional levels (Souza et al, 1998; Prusty et al, 2002).
In particular, perilipin A has been closely involved in lipid
storage and lipolysis in adipocytes in vivo and in vitro
(Tansey et al, 2001; Souza et al, 2002). Therefore, we spec-
ulate that perilipin might be involved in the formation of lipid
droplets along with the sebocytic differentiation.
In this study, we demonstrate that perilipin A is mainly
expressed in sebaceous glands in vivo and detected on the
surface of lipid droplets in differentiated hamster sebocytes
in vitro. Furthermore, we suggest that the regulation of per-
ilipin A expression is closely associated with that of lipo-
genesis in hamster sebocytes.
Abbreviations: 5a-DHT, 5a-dihydrotestosterone; DMEM/F12, Dul-
becco’s modified Eagle’s medium/Ham’s F12 medium; EGF,
epidermal growth factor; FBS, fetal bovine serum; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; PBS(), Ca2þ - and
Mg2þ -free phosphate-buffered saline; PPAR, peroxisome prolifer-
ation-activating receptor; TG, triacylglycerols
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Results
Localization of perilipin in sebaceous glands and se-
bocytes Since the expression of perilipin has been in-
volved in the formation of intracellular lipid droplets during
adipogenesis (Greenberg et al, 1991; Blanchette-Mackie
et al, 1995), we first examined whether perilipin might be
expressed in sebaceous glands in vivo. As shown in Fig 1A,
oil red O staining revealed lipid deposition in sebaceous
glands and ducts. In addition, an immunohistochemical
analysis detected perilipin in sebaceous glands, especially
at suprabasal regions rather than the basal cell layer of the
glands (Figs 1B and D), whereas there was no immunolog-
ical signal in the glands using non-immune IgG (Fig 1C).
Furthermore, when hamster sebocytes were differentiated
spontaneously to accumulate intracellular lipid droplets for
12 d (Fig 2A) (Sato et al, 2001), perilipin localized on the
surface of lipid droplets (Fig 2B).
Regulation of perilipin expression by insulin, EGF, and
5a-DHT in sebocytes Next, we examined the regulation of
perilipin expression by regulators of sebocytic differentia-
tion in cultured sebocytes. As shown in Fig 3A, sebocytes,
which were spontaneously differentiated during 12 d of cul-
tivation, were found to produce perilipin with a molecular
weight of approximately 57 kDa that was identical to ad-
ipocyte perilipin in differentiated mouse 3T3-L1 cells, indi-
cating that differentiated sebocytes expressed perilipin A
(Lu et al, 2001). When hamster sebocytes were treated with
insulin (0.1–100 nM) for 12 d, a concentration-dependent
increase in levels of intracellular triacylglycerols (TG), which
are the main component of sebum in humans and hamsters
(Zouboulis et al, 1991; Sato et al, 2001), was observed (Ta-
ble I). As shown in Figs 3A and B, western blot and RT-PCR
analyses showed that insulin (10 nM) augmented the pro-
duction of perilipin A (2.83  0.42 times, po0.05) due to
an increase of its mRNA expression (3.14  0.51 times,
po0.05) in the sebocytes. A similar result of the insulin
augmentation of perilipin A mRNA (2.7 kb) expression was
Figure 1
Expression of perilipin in sebaceous glands. Oil red O staining (A)
shows lipid deposition in sebaceous glands and ducts of auricles in
hamster skin. Immunohistochemical staining shows that perilipin is
expressed mainly in sebaceous glands (B and D), in contrast to neg-
ative control using non-immune rabbit IgG (C). Scale bars¼ 100 (A–C)
and 50 mm (D).
Figure2
Localization of perilipin on the surface of lipid droplets in cultured
hamster sebocytes. Oil red O staining (A) of hamster sebocytes at the
second passage cultured for 12 d. Immunostaining of perilipin (B)
shows that the protein is visualized as rings around the periphery of
intracellular lipid droplets of various sizes in hamster sebocytes. Scale
bars¼ 20 mm.
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obtained by Northern blot analysis (see Fig 5B, lane 2).
When the cells were similarly treated with 5a-DHT (10 nM),
an inducer of sebocytic differentiation (Zouboulis et al,
1994; Rosenfield et al, 1998; Sato et al, 2001), the produc-
tion and gene expression of perilipin A were augmented
(4.16  0.88 and 3.58  0.79 times, respectively; po0.05)
(Figs 3A and B). In contrast, in hamster sebocytes treated
with EGF (10 ng per mL), where no lipid formation was ob-
served (Sato et al, 2001; Akimoto et al, 2002), perilipin A
protein was not detected (Fig 3A). In addition, the levels of
perilipin A mRNA were decreased in the EGF-treated cells
(44.2%  15.3% vs untreated cells; po0.01) (Fig 3B).
Activation of peroxisome proliferation-activating recep-
tors (PPARs) increases the expression of perilipin A and
lipogenesis in sebocytes It has been reported that PPARa
and g are involved in the augmentation of lipid-droplet for-
mation in rat sebocytes (Rosenfield et al, 1999). Therefore,
we examined whether the activation of PPAR could augment
the expression of perilipin A along with an increase
of lipogenesis in hamster sebocytes. As shown in Fig 4,
hamster sebocytes constitutively expressed PPARa
(panel A, lane 1) and g1 (panel B, lane 1), which were of
the same mobility as those in differentiated mouse 3T3-L1
adipocytes. In addition, there was no significant change in
the levels of PPARa and g1 in insulin-differentiated se-
bocytes (lane 2) as compared with untreated cells. Further-
more, Table II shows that a PPARg ligand-activator,
troglitazone, increased levels of intracellular TG in a con-
centration-dependent manner, with 1-10 mM yielding a
maximum response. A PPARa ligand-activator, WY14643,
had a similar inducible activity against TG production, but
the same extent of the activity as troglitazone was observed
at a much higher concentration (100 mM) of WY14643. On
the other hand, western blot analysis (Fig 5A) showed that
troglitazone (10 mM) (lane 3) and WY14643 (100 mM) (lane 4)
increased the production of perilipin A in hamster sebocytes
(4.79  0.49 times, po0.01; and 2.64  0.57 times,
po0.05, respectively). In addition, the augmented produc-
tion of perilipin A resulted from an increase in levels of
its mRNA in troglitazone and WY14643-treated cells for
12 d (4.53  0.37 times, po0.01; and 2.62  0.40 times,
po0.05, respectively) (Fig 5B). Furthermore, as shown in Fig
6, the mRNA expression of perilipin A was found to increase
by troglitazone treatment for 4 d, whereas the effect of
WY14643 on its mRNA levels was observed for 7 d. The
augmentation of mRNA expression of perilipin A by insulin
and 5a-DHT, however, was not found to appear for 7 d.
These results suggest that the expression of perilipin A in
Table I. Concentration-dependent increase of TG production
by insulin in hamster sebocytes
Treatments nM
Levels of TG (lg per lg DNA)
(% of untreated cells)
None – 1.92  0.13 (100.0)
Insulin 0.1 2.38  0.23 (124.0)
1 2.68  0.29a (139.6)
10 2.73  0.27a (142.2)
100 2.89  0.20b (150.5)
apo0.05 between insulin-treated and untreated cells.
bpo0.01 between insulin-treated and untreated cells.
TG, triacylglycerols.
Figure 3
Regulation of perilipin A production and mRNA expression in
hamster sebocytes. Hamster sebocytes at the second passage were
treated without (lane 1) or with insulin (lane 2, 10 nM), epidermal growth
factor (EGF) (lane 3, 10 ng per ml), and 5a-dihydrotestosterone (5a-
DHT) (lane 4, 10 nM) for 12 d, and then cell lysates and isolated RNA
were subjected to western blot analysis of perilipin A (A), and to RT-
PCR of perilipin A (B) (32 cycles), and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA (C) (30 cycles), respectively. Four in-
dependent experiments were reproducible and typical data are shown.
3T3, differentiated mouse 3T3-L1 adipocytes.
Figure4
Expression of peroxisome proliferation-activating receptors
(PPARs) in hamster sebocytes. Cell lysates from untreated (lane 1)-
and insulin (lane 2, 10 nM)-treated sebocytes were subjected to west-
ern blot analysis for PPARa (A) and g (B). Note that relatively weak
bands smaller than PPARa (A) and g1 (B) are non-specific ones de-
tected using control rabbit IgG. Four independent experiments were
reproducible and typical data are shown. 3T3, differentiated mouse
3T3-L1 adipocytes.
Table II. PPAR ligands increase the levels of TG in hamster
sebocytes
Treatments lM
Levels of TG (lg per lg DNA)
(% of untreated cells)
None – 2.40  0.15 (100.0)
Troglitazone 0.1 3.40  0.02b (141.7)
1 4.66  0.28c (194.2)
10 4.65  0.99a (193.8)
WY14643 1 2.58  0.27 (107.5)
10 2.42  0.01 (100.8)
100 4.34  0.11c (180.8)
apo0.05 between PPAR ligand-treated and untreated cells.
bpo0.01 between PPAR ligand-treated and untreated cells.
cpo0.001 between PPAR ligand-treated and untreated cells.
PPAR, peroxisome proliferation-activating receptor; TG, triacylglycerols.
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sebocytes is upregulated by the activation of PPAR. Fur-
thermore, the regulation of perilipin A expression by insulin
and 5a-DHT may differ from that by PPAR activators.
Discussion
Perilipin has been identified as a prominent phosphoprotein
that localizes on the surface of intracellular lipid droplets,
which consist mainly of TG, in rat adipose cells and differ-
entiated mouse 3T3-L1 adipocytes (Greenberg et al, 1991,
1993). In addition, it has been reported that steroidogenic
cells, such as adrenal cortical cells and Leydig cells, store
cholesterol esters in intracellular lipid droplets, which are
coated with perilipin (Servetnick et al, 1995). Since there has
been no expression of perilipin in rat tissues from the testes,
heart, brain, liver, and lung (Greenberg et al, 1991, 1993),
perilipin is likely to participate restrictedly in the intracellular
lipid storage of adipocytes and steroidogenic cells. In this
study, we demonstrate that perilipin is expressed in hamster
sebaceous glands, where its expression is predominant
in suprabasal cells with accumulating sebum rather than in
basal cells. In addition, in differentiated sebocytes in vitro,
perilipin localizes on the periphery of intracellular lipid drop-
lets. Therefore, we propose that perilipin becomes a se-
bocytic differentiation marker.
It has been reported that perilipin plays important roles in
lipid metabolism, including lipogenesis and lipolysis in ad-
ipocytes and steroidogenic cells, which in turn may be as-
sociated with providing bodily energies and the synthesis of
steroid hormones, respectively (Londos et al, 1999). Souza
et al (2002) have reported that adenovirus-mediated over-
expression of perilipin A at the surface of lipid droplets
causes the formation of larger and more numerous droplets
by increasing TG synthesis in NIH3T3 ACS1/FATP1 cells. In
addition, previous reports of perilipin knockout mice (Marti-
nez-Botas et al, 2000; Tansey et al, 2001) have shown that
adipose tissue mass and visible fat droplets in brown fat
cells are reduced in the null mice compared with wild-type
mice. Therefore, it is likely that the augmentation of perilipin
production results in stimulating lipogenesis. In this in vitro
culture system, hamster sebocytes were found to differen-
tiate spontaneously to accumulate lipid droplets and to
express perilipin A during cultivation concomitantly. In
addition, we demonstrate that the expression of perilipin A
in sebocytes is augmented transcriptionally by insulin along
with an increase in levels of TG in droplets. Therefore, we
suggest strongly the involvement of perilipin A in the up-
regulation of lipogenesis in sebocytes. Further experiments
to investigate perilipin A functions with knockout mice are
being planned. Moreover, taken together with the fact that
insulin is a well-known inducer of adipogenesis in mouse
preadipocytes (Klemm et al, 2001; Prusty et al, 2002), it is
likely that insulin functions as a crucial inducer of sebocytic
lipogenesis in sebaceous glands (Deplewski and Rosen-
field, 1999) by a mechanism in which insulin augments both
TG synthesis and perilipin A expression.
With regard to the regulation of perilipin expression,
Souza et al (1998) reported that tumor necrosis factor-a
decreases the expression of perilipin A and B in 3T3-L1
adipocytes. Prusty et al (2002) also reported that insulin
augments the production of perilipin in differentiated 3T3-L1
cells. In this study, we demonstrate that EGF suppresses
but 5a-DHT augments the production and gene expression
of perilipin A in hamster sebocytes. As far as androgen
regulation of perilipin expression is concerned, a recent
study by Dicker et al (2004) reported that testosterone does
not influence perilipin production in differentiated human
subcutaneous preadipocytes. Thus, it is likely that the an-
drogen regulation of perilipin expression differs between
sebocytes and adipocytes. Moreover, taken together with
our previous findings that EGF and 5a-DHT suppress and
increase the synthesis of TG in cultured hamster sebocytes,
respectively (Sato et al, 2001), we suggest that EGF-medi-
ated suppression and 5a-DHT-mediated augmentation of
Figure 6
Differential regulation of mRNA expression of perilipin A by of
peroxisome proliferation-activating receptor (PPAR) activators,
insulin, and 5a-dihydrotestosterone (5a-DHT) in hamster se-
bocytes. Hamster sebocytes at the 3rd passage were treated without
(lane 1) or with troglitazone (lane 2, 10 mM), WY14643 (lane 3, 100 mM),
insulin (lane 4, 10 nM), and 5a-DHT (lane 5, 10 nM) for indicated pe-
riods, and then isolated RNAs were subjected to RT-PCR of perilipin A
as described in Fig 3. The relative amounts of perilipin A mRNA were
quantified by densitometric scanning and expressed by taking the val-
ue for untreated cells as 100%. Data are shown as the mean  SD of
three independent experiments. Significantly different from untreated
cells (po0.01).
Figure 5
Transcriptional augmentation of perilipin A production by ligand-
activators of peroxisome proliferation-activating receptor (PPAR)a
and c in hamster sebocytes. Hamster sebocytes at the 3rd passage
were treated without (lane 1) or with insulin (lane 2, 10 nM), troglitazone
(lane 3, 10 mM), and WY14643 (lane 4, 100 mM) for 12 d, and then cell
lysates and isolated RNA were subjected to western blot analysis of
perilipin A (A) and to northern blot analysis of perilipin A (B) and glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) mRNA (C), respec-
tively. Three independent experiments were reproducible and typical
data are shown.
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lipogenesis are associated with the alteration of perilipin A
expression.
Rosenfield et al (1999) reported that rat sebocytes ex-
press PPAR a, d, and g1, whose activation by their ligand
activators augments the lipid formation. Chen et al (2003)
also reported that mRNA of PPAR a, d, g1, and g2 are de-
tected in immortalized human sebocyte SZ95, and the ac-
tivation of PPARd by linoleic acid causes an increase of lipid
production. In this study, hamster sebocytes express at
least PPARa and g1, and both WY14643 and troglitazone
augment the production of TG, suggesting that the activa-
tion of PPARa or g1 is requisite for promoting lipogenesis in
hamster sebocytes. Moreover, we found that perilipin A
production in hamster sebocytes is transcriptionally upreg-
ulated by WY14643 and troglitazone. When we were pre-
paring this manuscript, the promoter sequence of murine
perilipin gene was reported to have a functional PPAR-re-
sponsive element (Arimura et al, 2004; Nagai et al, 2004;
Shimizu et al, 2004). These reports strongly support the
notion that the expression of perilipin is dependent on the
activation of PPARa or g1 during the differentiation of ham-
ster sebocytes. Furthermore, we demonstrate that although
troglitazone and WY14643 cause increases in perilipin A
expression in less than 7 d, the augmentation of its mRNA
expression by insulin and 5a-DHT appears after 7 d, in
which sebocyte differentiation has been shown to occur
(Sato et al, 2001). Therefore, it may be suggested that in-
sulin and 5a-DHT-mediated perilipin A expression might be
related to the differentiation of sebocytes through an indi-
rect activation of PPAR or a PPAR-independent pathway(s).
Further experiments will be required to clarify this issue.
In conclusion, we demonstrate that perilipin A is ex-
pressed in sebaceous glands and localized on the surface
of intracellular lipid droplets in differentiated hamster se-
bocytes. In addition, the production and mRNA expression
of perilipin A are transcriptionally augmented by insulin, 5a-
DHT, and ligand-activators for PPARa and g, whereas they
are suppressed by EGF in sebocytes. Therefore, these re-
sults suggest the possibility that perilipin A is involved in the
formation of lipid droplets along with sebocytic differentia-
tion. Moreover, perilipin is likely to be a therapeutic target
molecule for prevention of sebaceous gland disorders, such
as acne vulgaris and seborrhea.
Materials and Methods
Cell culture and treatments Hamster sebocytes have been es-
tablished from sebaceous glands of auricles of 5-wk-old male
golden hamsters as described previously (Ito et al, 1998; Sato et al,
2001). Sebocytes (2.35  104 cells per cm2) in Dulbecco’s modified
Eagle’s medium/Ham’s F12 medium (1:1) (DMEM/F12) (Invitrogen,
Carlsbad, California) supplemented with 6% (vol/vol) heat-dena-
tured fetal bovine serum (FBS) (Asahi Techno Glass, Tokyo, Japan),
2% (vol/vol) human serum (ICN Biochemicals, Costa Mesa, Cal-
ifornia), 0.68 mM L-glutamine (Invitrogen), and recombinant human
EGF (10 ng per mL) (Progen Biotechnik GmbH, Heidelberg, Ger-
many) were plated into 35- or 60-mm diameter culture dishes
(Becton Dickinson, Tokyo, Japan) for 24 h to achieve complete cell
adhesion. Next, the cells were treated with insulin (10 nM) (Sigma
Chemical, St Louis, Missouri), EGF, 5a-DHT (10 nM) (Wako Pure
Chemical, Osaka, Japan), troglitazone (0.1–10 mM) (kindly provided
by Sankyo, Tokyo, Japan), and WY14643 (1–100 mM) (Cayman
Chemical, Ann Arbor, Michigan) in DMEM/F12 supplemented with
heat-denatured FBS, human serum, and L-glutamine for up to 12 d.
Mouse 3T3-L1 preadipocytes (Health Science Research Re-
sources Bank, Osaka, Japan) were cultured in DMEM/F12 sup-
plemented with 10% (vol/vol) FBS, 14.3 mM NaHCO3, 16.4 mM
biotine, 7.7 mM D-panthotenate, 5 mM L-glutamine, 25 mM
glucose, and 15 mM Hepes (pH 7.4). The confluent cells were
differentiated by adding dexamethasone (1 mM), 3-isobutyl-1-
methyl-xanthine (500 mM) (Sigma), and insulin (2 mM) for 48 h,
and thereafter were maintained every 2 d in the fresh medium
supplemented with insulin (2 mM) for 6 d.
Oil red O staining Skin from auricles of 5-wk-old male golden
hamsters was snap-frozen in liquid nitrogen, and then the frozen
tissues were sectioned into 8-mm-thick sections, which were in
turn washed in distilled H2O, and incubated in 60% (vol/vol) is-
opropanol. Sections and cultured sebocytes were stained with
0.3% (wt/vol) oil red O (Sigma) in isopropanol:distilled H2O (3:2,
vol:vol) at 371C for 15 min, and then viewed with a light microscope
furnished with a digital camera (Olympus Optical, Tokyo, Japan).
Sections were also counterstained with Mayer’s hematoxylin so-
lution (Wako).
Immunostaining of perilipin Tissues from auricle skin were fixed
with 10% (wt/vol) formalin neutral buffer (Mildform, Wako) and
embedded in paraffin. The fixed tissue sections with 4 mm thick-
ness were placed on slide glasses, rehydrated, and then incubated
in 3% (vol/vol) H2O2 in methanol for 10 min to block endogenous
peroxidase activity. After blocking non-specific reactivity with 10%
(wt/vol) normal goat serum, sections were incubated with rabbit
polyclonal antibody against mouse perilipin (200 times dilution)
(Morimoto et al, 2000) for 1 h at room temperature, and then
exposed to Histofine Simple Stain Rat MAX-PO(MULTI) (Nichirei,
Tokyo, Japan). Reaction products were visualized using 3,30di-
aminobenzidine solution (Nichirei), and sections were counter-
stained with Mayer’s hematoxylin solution before clearing and
mounting. For immunofluorescent staining of perilipin in sebocytes,
cells were grown on Lab-Tek chamber slides (Nunc, Naperville,
Illinois), and then fixed in 4% (vol/vol) paraformaldehyde for 20 min
at room temperature. The cells on slides were washed with Ca2þ -
and Mg2þ -free phosphate-buffered saline [PBS()], and then in-
cubated with 0.1% (wt/vol) Triton X-100 in ice-cold PBS() for
10 min at 41C. The cells were subjected to blocking with 5% (wt/vol)
normal goat serum for 15 min, and then treated with the perilipin
antibody at room temperature. Thereafter, the cells were incubated
with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG
(Chemicon International, Temecula, California) for 1 h at room
temperature. The immunostained tissues and cells were viewed
with a fluorescence and differential-interference microscope fur-
nished with a digital camera (Olympus).
Measurement of intracellular TG The harvested sebocytes were
sonicated at 41C, and then levels of intracellular TG in the cell
lysate were measured with an absorbance at 590 nm using Liqui-
tech TG-II (Roche Diagnostics, Tokyo, Japan) according to the
manufacturer’s instructions. The amount of TG was calculated us-
ing an authentic trioleinate-standard solution (0.6 mg per mL). In
addition, DNA content in the cells was measured according to the
method described previously (Sato et al, 2001).
Western blot analysis Cells were scraped with 1% (vol/vol)
Nonidant P-40 and 0.1% (wt per vol) SDS in PBS(), and then
homogenated by passing through a 21-gauge needle. The cell
homogenate was centrifuged at 15,000  g for 20 min at 41C,
and a resultant supernatant was used for western blot analysis.
The sample was subjected to SDS-polyacrylamide gel elect-
rophoresis with 10% (wt/vol) acrylamide gel for perilipin and
10%–20% (wt/vol) gradient acrylamide gel (Bio-Rad Laboratories,
Tokyo, Japan) for PPAR. Proteins separated in the gels were
electrotransferred onto nitrocellulose membranes, and the mem-
branes were reacted with rabbit antibodies against mouse perilipin,
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human PPARa (H-98), and human PPARa (H-100) (Santa Cruz
Biotechnology, Santa Cruz, CA), which were then complexed with
peroxidase-conjugated goat anti-rabbit IgG. Immunoreactive per-
ilipin, PPARa, and PPARg were visualized with enhanced chemi-
luminescence–western blotting detection reagents (Amersham
Biosciences, Tokyo, Japan), according to the manufacturer’s in-
structions. The relative amounts of these proteins were quantified
by densitometric scanning using the Image Analyzer LAS-1000
plus (Fuji Photo Film, Tokyo, Japan).
Semiquantitative RT-PCR Gene expression of perilipin in cul-
tured hamster sebocytes was monitored by RT-PCR, as described
previously (Hirata et al, 2003). RNA in hamster sebocytes was iso-
lated by ISOGEN (Nippon Gene, Tokyo, Japan) according to the
manufacturer’s instructions. The isolated total RNA (3 mg) was
subjected to first-strand cDNA synthesis and then one-tenth of the
generated cDNA was used for PCR amplification for perilipin and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Primers for
human perilipin (DDBJ/EMBL/GenBank database: AB005293):
50-ACCTTGCTGGATGGAGACC-30 (sense, 146–164 bp) and
50-CCAGGACCTTGTCTGAAGT-30 (antisense, 536–554 bp), and
hamster GAPDH (DDBJ/EMBL/GenBank database: U10983): 50-
CCCTTCATTGACCTCAACTAC-30 (sense, 70–90 bp) and 50-AGT-
GAGCTTCCCGTTCAGCT-30 (antisense, 632–651 bp) were synthe-
sized and utilized for the amplification. The amplification was
performed at 921C for 45 s, 541C for 60 s, and 721C for 90 s after
initial denaturation at 921C for 2 min. We confirmed the linear am-
plification of hamster perilipin A between 30 and 34 cycles, and
hamster GAPDH between 28 and 32 cycles. The amplified PCR
products of hamster perilipin A (409 bp) and GAPDH (582 bp) were
analyzed with 1% (wt/vol) agarose gel and visualized by ethidium-
bromide staining. In addition, the PCR products were subcloned
into pGEM-T Easy vectors (Promega, Madison, Wisconsin), fol-
lowed by confirmation of their cDNA sequences with Thermo Se-
quenase II dye terminator cycle sequencing kit (Amersham
Biosciences), according to the manufacturer’s instructions. The
cDNA sequence of hamster perilipin A (DDBJ/EMBL/GenBank da-
tabase: AB091681) is homologous to that of rat and human per-
ilipin A, with 92.9% and 89.0%, respectively.
Northern blot analysis Isolated total RNA (10 mg) was denatured
and electrophoresed on 1% (wt/vol) formaldehyde-denatured
agarose gel and then transferred onto a nylon membrane
(GeneScreen; DuPont, Boston, Massachusetts). The membrane
was hybridized with 32P-labeled cDNA probes for mouse perilipin A
(Morimoto et al, 2000) and human GAPDH (Clontech Laboratories,
Palo Alto, California). The relative amounts of their steady-state
mRNA were quantified by densitometric scanning using Image
Analyzer LAS-1000 plus (Fuji) and indicated after correction for the
levels of GAPDH mRNA.
Animal Care The animals had free access to food and water
according to the Guidelines of Experimental Animal Care issued by
the Prime Minister’s Office of Japan. The experimental protocol
was approved by the Committee of Animal Care and Use of Tokyo
University of Pharmacy and Life Science.
Statistical analysis A one-way ANOVA was used for sta-
tistical analysis, and then the Fisher test was applied when
multiple comparisons were performed.
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